Rohto Pharmaceutical: (Progress of Disclosure) Announcement of extension of the tender offer period for shares of Eu Yan Sang International Ltd., a Singaporean traditional chinese medicine manufacturing and sales company.
Rohto Pharmaceutical: Announcements of individual stocks regarding the new management structure.
Rohto Pharmaceutical: 【Correction and Apology】Rohto Pharmaceutical and Recursive, an AI startup, have entered into a capital business partnership to realize a well-being society using AI.
Rohto Pharmaceutical: Rohto Pharmaceutical and AI startup Recursive have entered into a capital business partnership to realize a well-being society using AI.
Rohto Pharmaceutical: Independent Company Executives Declaration
Rohto Pharmaceutical: Acquisition of shares in the Austrian pharmaceutical company Mono Chemical Farm Products.
Rohto Pharmaceutical: Regarding the acquisition of shares of Mono chem-pharm Produkte GmbH, an Austrian pharmaceutical company.
Rohto Pharmaceutical: Announcements of individual stocks regarding the public tender offer for shares of Eu Yan Sang International Ltd., a Singaporean traditional chinese medicine manufacturer and distributor, by Soar R2M Pte. Ltd.
Rohto Pharmaceutical: [Corrections and apologies] Notice regarding changes in officers
Rohto Pharmaceutical: Notice regarding changes in officers
Rohto Pharmaceutical: Consolidated financial results for the fiscal year ended March 31, 2024
Rohto Pharmaceutical: [Update] [Postponed] Stock Acquisition and Tender Offer for Yu Yangsan International Co., Ltd.
Rohto Pharmaceutical: Acquisition of shares in and tender offer for Eu Yan Sang International Ltd, a Singapore health and wellness manufacturing and sales company
Rohto Pharmaceutical: Acquisition of shares in the Singaporean Chinese medicine manufacturing and sales company Eu Yan Sang International Ltd. (making it a subsidiary company) and commencement of a public tender offer against the company
Rohto Pharmaceutical: Capital alliance and license agreement concluded with therapeutic application development startup S-Alpha
Rohto Pharmaceutical: Notice regarding investment in FiNC Technologies, Inc.
Rohto Pharmaceutical: Notice regarding a capital alliance with Innojin, a university startup working on medical DX
Rohto Pharmaceutical: Notice Concerning Revisions to the Earnings Forecast
Rohto Pharmaceutical: Results of Operations for the First Nine Months of the Fiscal Year Ending March 31, 2024
Rohto Pharmaceutical: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Nine Months Ended December 31, 2023)
No Data